These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6791924)

  • 41. [Reversion of angina refractory to the use of nitrates with the utilization of intravenous verapamil during heart catheterization].
    Manfroi WC; Vieira SR; Goldim JR; de Freitas FM; Faraco EZ
    Arq Bras Cardiol; 1987 Mar; 48(3):157-60. PubMed ID: 3118857
    [No Abstract]   [Full Text] [Related]  

  • 42. [Dazoxiben compared with verapamil in the treatment of stable angina pectoris evaluated by an exercise test].
    Mogensen F; Rasmussen V; Kjøller E; Knudsen JB; Gormsen J
    Ugeskr Laeger; 1985 Jul; 147(29):2299-302. PubMed ID: 3904110
    [No Abstract]   [Full Text] [Related]  

  • 43. Sustained-release verapamil in stable angina.
    Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB
    Br J Clin Pract Suppl; 1988 Apr; 60():20-3. PubMed ID: 3151265
    [No Abstract]   [Full Text] [Related]  

  • 44. Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris.
    Naafs MA; de Boer AC; Koster RW; Klazen CW; Dunning AJ
    Eur Heart J; 1984 Sep; 5(9):705-9. PubMed ID: 6437815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitroderm TTS in exercise-induced angina pectoris--a randomized double-blind study.
    Colombo G; Favini G; Aglieri S; Pollavini G; de Vita C
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):211-4. PubMed ID: 3922903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Double-blind comparison of verapamil and propranolol in the therapy of unstable angina].
    Capucci A; Bracchetti D; Carini G; Di Ciò G; Maresta A; Magnani B
    Cardiologia; 1982; 27(5):447-52. PubMed ID: 6765439
    [No Abstract]   [Full Text] [Related]  

  • 47. Abrupt change from propranolol to verapamil. Safety and feasibility in stable angina pectoris.
    Winniford MD; Fulton KL; Hillis LD
    Arch Intern Med; 1986 Apr; 146(4):795. PubMed ID: 3963962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Verapamil in effort angina: a multi-centre study].
    Vincenzi M; Braito E; Cappelletti F; Caponnetto S; De Ponti C; Distante R; Masoni A; Palmieri M; Ricciardelli B; Uslenghi E; Zanini S
    G Ital Cardiol; 1982; 12(9):660-5. PubMed ID: 6820344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of the anti-ischemia effect of nisoldipine and verapamil. Double-blind randomized cross-over and placebo-controlled acute and long-term study].
    Brügmann U; Blasini R; Rudolph W
    Herz; 1984 Aug; 9(4):244-52. PubMed ID: 6434387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical evaluation of verapamil in angina pectoris.
    Sandler G; Clayton GA; Thornicroft SG
    Br Med J; 1968 Jul; 3(5612):224-7. PubMed ID: 4969551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antia-angina effect of verapamil through the clinical and ergometric evaluation].
    Castro I; Pereira FA; Rodrigues R
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():75-7. PubMed ID: 329812
    [No Abstract]   [Full Text] [Related]  

  • 52. The long-term treatment of stable angina pectoris with verapamil.
    Miller AJ; Grais IM; Kaminsky LA
    J Clin Pharmacol; 1990 Oct; 30(10):916-21. PubMed ID: 2229452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind crossover study of diphenylhydantoin in angina pectoris.
    Taylor CR
    Chest; 1974 Oct; 66(4):422-7. PubMed ID: 4213041
    [No Abstract]   [Full Text] [Related]  

  • 54. [Coronary sclerosis and angina pectoris. Clinical, double-blind study using Stenoptin].
    Müller R
    MMW Munch Med Wochenschr; 1978 Jun; 120(24):843-4. PubMed ID: 351379
    [No Abstract]   [Full Text] [Related]  

  • 55. Once-daily verapamil--an objective evaluation in stable angina pectoris using treadmill exercise testing.
    Raftery EB
    Br J Clin Pract Suppl; 1985 Jun; 42():17-23. PubMed ID: 3929824
    [No Abstract]   [Full Text] [Related]  

  • 56. Additive antianginal effect of verapamil in patients receiving propranolol.
    Bassan M; Weiler-Ravell D; Shalev O
    Br Med J (Clin Res Ed); 1982 Apr; 284(6322):1067-70. PubMed ID: 6802408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparison of the efficacy of verapamil and diltiazem in stable exercise angina. A double-blind and crossover study].
    Belin A; Grieu P; Mabire JP; Kleszcz A; Sesboué B; Breut C; Scanu P; Albessard F; Grollier G; Potier JC
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):393-8. PubMed ID: 2108634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose related efficacy of betaxolol in combination with nitroglycerin in patients with angina pectoris: a double blind cross-over study.
    Stroobandt R; Kesteloot H
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):299-309. PubMed ID: 6143538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of angina pectoris.
    Proctor JD; Wasserman AJ; Gamble E
    Br Med J; 1968 Nov; 4(5629):515-6. PubMed ID: 4972321
    [No Abstract]   [Full Text] [Related]  

  • 60. An objective evaluation of once-daily sustained-release verapamil (480 mg) in chronic stable angina.
    Rodrigues EA; DasGupta P; Hains AD; Raftery EB
    Eur J Clin Pharmacol; 1988; 34(5):531-2. PubMed ID: 3060361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.